We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $316.91 which represents a decrease of $-2.31 or -0.72% from the prior close of $319.22. The stock opened at $320.58 and touched a ...

Discover why Amgen is a reliable wealth compounder with strong Q3 results, a promising pipeline, debt reduction, and ...

Amgen ( AMGN 1.68%), a leader in biotechnology, released its third-quarter 2024 financial results on Oct. 30. The company ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...

Shares of Amgen Inc. AMGN inched 0.06% higher to $317.17 Monday, on what proved to be an all-around positive trading session ...

Amgen is also targeting 2024 revenue growth of around 18%, projecting confidence in the significant opportunities ahead. Beyond the products currently on the market, Amgen benefits from a pipeline ...

Bernstein analyst Courtney Breen maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $380.00.

Get the latest updates on Amgen's upcoming Q3 earnings results, including insights from analysts on key products and trial ...

Right now, Amgen possesses a Zacks Rank of #3 (Hold ... the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Biomedical and ...

Amgen also has a growing biosimilar portfolio. Amgen's Current Market Status With a volume of 1,450,738, the price of AMGN is down -1.49% at $314.9. RSI indicators hint that the underlying stock ...